BIOREM Inc.
BRM.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.51% | -15.79% | 21.38% | 26.84% | 46.66% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.51% | -15.79% | 21.38% | 26.84% | 46.66% |
| Cost of Revenue | 6.61% | -6.34% | 27.44% | 36.23% | 48.55% |
| Gross Profit | 24.79% | -35.93% | 7.47% | 6.02% | 41.78% |
| SG&A Expenses | 7.45% | -8.75% | 25.91% | 26.44% | 41.90% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 100.00% | -1,616.67% | -- | -- | -- |
| Total Operating Expenses | 7.10% | -7.02% | 26.68% | 33.96% | 46.90% |
| Operating Income | 43.61% | -56.66% | -7.13% | -10.79% | 44.98% |
| Income Before Tax | 49.89% | -58.90% | -7.81% | -7.57% | 48.12% |
| Income Tax Expenses | 34.83% | -55.41% | 3.80% | 6.02% | 78.86% |
| Earnings from Continuing Operations | 55.35% | -60.05% | -11.41% | -11.69% | 39.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 55.35% | -60.05% | -11.41% | -11.69% | 39.44% |
| EBIT | 43.61% | -56.66% | -7.13% | -10.79% | 44.98% |
| EBITDA | 40.98% | -52.82% | -1.28% | -4.62% | 48.57% |
| EPS Basic | 59.82% | -60.67% | -12.16% | -12.07% | 39.51% |
| Normalized Basic EPS | 53.90% | -59.58% | -8.61% | -7.93% | 48.34% |
| EPS Diluted | 69.69% | -62.26% | -17.26% | -18.02% | 34.63% |
| Normalized Diluted EPS | 59.43% | -60.71% | -14.66% | -14.79% | 39.37% |
| Average Basic Shares Outstanding | 4.29% | 5.37% | 5.21% | 4.69% | -0.09% |
| Average Diluted Shares Outstanding | -2.24% | 3.59% | 5.27% | 9.51% | 12.81% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |